ApicHope Pharmaceutical Co., Ltd

XSEC:300723 Stock Report

Market Cap: CN¥6.9b

ApicHope Pharmaceutical Future Growth

Future criteria checks 4/6

ApicHope Pharmaceutical is forecast to grow earnings and revenue by 53.3% and 19.4% per annum respectively. EPS is expected to grow by 53.2% per annum. Return on equity is forecast to be 11.2% in 3 years.

Key information

53.3%

Earnings growth rate

53.2%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate19.4%
Future return on equity11.2%
Analyst coverage

Low

Last updated16 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300723 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,481386N/A6284
12/31/20253,244397N/A5755
12/31/20242,526261N/A5154
6/30/20242,1502655438N/A
3/31/20242,410174135480N/A
12/31/20232,503185124458N/A
9/30/20232,515307119416N/A
6/30/20232,641341123511N/A
3/31/20232,480322-21480N/A
1/1/20232,280291-130476N/A
9/30/20222,161285-153511N/A
6/30/20222,151344-157540N/A
3/31/20222,200319-176455N/A
12/31/20212,199307-123438N/A
9/30/20212,135317-133388N/A
6/30/20211,978263-163279N/A
3/31/20211,851250-63341N/A
12/31/20201,675226-39275N/A
9/30/20201,640173-51201N/A
6/30/20201,51511778249N/A
3/31/20201,64113828144N/A
12/31/20191,637144175281N/A
9/30/20191,537243223301N/A
6/30/20191,435234169275N/A
3/31/20191,39521924297N/A
12/31/20181,430208-18239N/A
9/30/20181,42618023263N/A
6/30/20181,477167-10185N/A
3/31/20181,467166N/A186N/A
12/31/20171,380157N/A158N/A
9/30/20171,399156N/A109N/A
12/31/20161,251137N/A146N/A
12/31/20151,02860N/A35N/A
12/31/201479340N/A9N/A
12/31/201350833N/A136N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300723's forecast earnings growth (53.3% per year) is above the savings rate (2.9%).

Earnings vs Market: 300723's earnings (53.3% per year) are forecast to grow faster than the CN market (22.9% per year).

High Growth Earnings: 300723's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300723's revenue (19.4% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 300723's revenue (19.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300723's Return on Equity is forecast to be low in 3 years time (11.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y